Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Usana Health Sciences (USNA) Inventory (2016 - 2026)

Usana Health Sciences (USNA) has disclosed Inventory for 15 consecutive years, with $90.8 million as the latest value for Q3 2025.

  • On a quarterly basis, Inventory rose 41.88% to $90.8 million in Q3 2025 year-over-year; TTM through Sep 2025 was $90.8 million, a 41.88% increase, with the full-year FY2024 number at $69.7 million, up 13.48% from a year prior.
  • Inventory was $90.8 million for Q3 2025 at Usana Health Sciences, up from $83.3 million in the prior quarter.
  • In the past five years, Inventory ranged from a high of $98.3 million in Q1 2022 to a low of $60.1 million in Q3 2023.
  • A 5-year average of $76.5 million and a median of $71.6 million in 2024 define the central range for Inventory.
  • Peak YoY movement for Inventory: skyrocketed 44.71% in 2021, then tumbled 33.91% in 2023.
  • Usana Health Sciences' Inventory stood at $96.3 million in 2021, then tumbled by 30.34% to $67.1 million in 2022, then decreased by 8.4% to $61.5 million in 2023, then grew by 13.48% to $69.7 million in 2024, then soared by 30.18% to $90.8 million in 2025.
  • Per Business Quant, the three most recent readings for USNA's Inventory are $90.8 million (Q3 2025), $83.3 million (Q2 2025), and $73.6 million (Q1 2025).